2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 32539832 | Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy. | 2020 Jun 15 | 1 |
| 2 | 26467280 | Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus. | 2015 Dec | 5 |